Nektaria Karavas | Business Development
Aptar

Nektaria Karavas is the Global Director of Business Development for Nasal Vaccines, Antivirals and Immuno-stimulants at Aptar Pharma. Ms. Karavas joined Aptar Pharma in 2004 and has held various commercial roles executing long-term strategy within key customer and global accounts in North America focusing on nasal drug delivery.
She has contributed to multiple nasal development programs, supported commercial scale up  and product launches for New Drug Applications (NDA) using an Aptar delivery device for key pharmaceutical clients across different therapeutic indications.
Nektaria holds a Bachelor of Science from McGill University, Montreal, Canada